Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Akcakanat

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
American Journal of Surgery|December 28, 1999
Correlation between teaching ability and examination scoresA Akcakanat, F Agalar
Oncogenesis|October 10, 2017
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancerS-U Woo, T Sangai, A Akcakanat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†A M Gonzalez-Angulo, A Akcakanat, S Liu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
American Journal of Surgery|December 28, 1999
Correlation between teaching ability and examination scoresA Akcakanat, F Agalar
Oncogenesis|October 10, 2017
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancerS-U Woo, T Sangai, A Akcakanat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†A M Gonzalez-Angulo, A Akcakanat, S Liu, et al.
Pageof 1